|Drug Patent Number||Company||Drug Patent Title||Drug Patent Expiry||Activity Alert|
|These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US11540981||BIOFRONTERA||Nanoemulsion formulation with improved stability and cell penetration|| |
(4 years from now)
|US11235169||BIOFRONTERA||Illumination device for photodynamic therapy, method for treating a skin disease and method for operating an illumination device|| |
(16 years from now)
Market Authorisation Date: 10 May, 2016
Treatment: Topical lesion-directed and field-directed treatment of actinic keratosis of the face and scalp with photodynamic therapy by positioning an illumination device in an appropriate distance and illuminat...